SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: JGoren who wrote (869)11/4/1999 1:23:00 AM
From: Adam Nash  Respond to of 1906
 
Biogen halted all testing of its Antova (sp?) drug - worries about blood clotting, I think.

It has been bad news for Biogen, a biotech bellweather, that I think it hurting the sector recently. First they halted some tests, then all.